Roles of A beta and carboxyl terminal peptide fragments of amyloid precursor protein in Alzheimer disease

Citation
Yh. Suh et al., Roles of A beta and carboxyl terminal peptide fragments of amyloid precursor protein in Alzheimer disease, J NEUR TR-S, (58), 2000, pp. 65-82
Citations number
56
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
ISSN journal
03036995 → ACNP
Issue
58
Year of publication
2000
Pages
65 - 82
Database
ISI
SICI code
0303-6995(2000):58<65:ROABAC>2.0.ZU;2-3
Abstract
Several lines of evidence indicate that A beta may play an important role i n the pathogenesis of AD. However, there are several discrepancies between the production of A beta and the development of the disease. Thus, A beta may not be the sole active fragment of beta -amyloid precursor protein (beta APP) in the neurotoxicity assiciated with AD. We focused on the amyloidegenic carboxyl terminal fragments of beta APP con taining the full length of A beta (CT105). We synthesized a recombinant car boxyl-terminal 105 amino acid fragment of beta APP and examined the effects of CT105 and A beta on cultured neurons, Ca++ uptake into rat brain micros omes, Na+-Ca++ exchange activity, ion channel forming activity in lipid bil ayers and passive avoidance performance of mice. Our results suggest that the cytotoxic and channel inducing effects of CT10 5 are much more potent than that of A beta and toxic mechanisms of CT105 ar e different from those of A beta. Taken together, these lines of evidence postulate that CT is an alternative toxic element important in the generation of the symptoms common to AD.